GlassScriptPhysician profile
Lauren Evans
NPI 1144451741
$3,705.57
in general payments reported to CMS, 2019-2025
20 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $677 · 2020: $95.14 · 2021: $644 · 2022: $599 · 2023: $641 · 2024: $864 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,691.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $821.37 | 2020-2024 | Acthar |
| Allergan, INC. | $471.38 | 2019-2022 | |
| Alcon Vision LLC | $443.87 | 2019-2025 | Total30, Precision7, Tryptyr |
| Glaukos Corporation | $363.01 | 2024 | Ce-Marked Kxla System, Photrexa |
| Novartis Pharmaceuticals Corporation | $330.83 | 2021-2023 | |
| Bausch & Lomb Americas INC. | $279.87 | 2023-2024 | Miebo, Xiidra, Vyzulta |
| Mallinckrodt Enterprises LLC | $191.33 | 2019 | |
| Oyster Point Pharma, INC. | $132.25 | 2022-2023 | Tyrvaya |
| Medical Device Business Services, INC. | $107.69 | 2022 | |
| Sun Pharmaceutical Industries INC. | $87.14 | 2019-2025 | |
| Shire North American Group INC | $77.71 | 2019 | |
| Dompe US, INC. | $74.18 | 2019-2024 | Oxervate |
| Abbvie INC. | $60.58 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $56.17 | 2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $54.18 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $49.39 | 2023 | Myday Contact Lens |
| Biotissue Holdings INC. | $39.42 | 2023 | |
| Harrow Eye, LLC | $26.79 | 2025 | Vevye |
| Apellis Pharmaceuticals, INC. | $20.23 | 2025 | Syfovre |
| Quidel Corporation | $18.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.